J&J Launches AI in Surgery Funding via Polyphonic™ Fund
J&J invests $100M in AI in surgery funding to drive smarter surgical solutions.
Read MorePosted by Shajini | Jun 27, 2025 | News, Orthopaedics
J&J invests $100M in AI in surgery funding to drive smarter surgical solutions.
Read MorePosted by Shajini | Jun 27, 2025 | FDA Updates, News, Orthopaedics |
Stryker FDA-cleared InCompass Ankle; protein degrader partnerships drive innovation.
Read MorePosted by Shajini | Jun 27, 2025 | Dealstreet, News |
Sanofi, Gilead sign License Agreement with Kymera for protein degrader programs.
Read MorePosted by Shajini | Jun 27, 2025 | News, Regulatory
Hereditary angioedema therapy by CSL Behring gains positive nod in Germany.
Read MorePosted by Shajini | Jun 27, 2025 | FDA Updates, News, Regulatory |
FDA import ban issued on Olympus medical devices from Japan for quality violations.
Read More